Lineage Cell Therapeutics
LCTX
#8551
Rank
A$0.39 B
Marketcap
A$1.55
Share price
-4.31%
Change (1 day)
-13.36%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2026 (TTM): -A$33.99 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are A$14.77 Million. In 2025 the company made an earning of -A$30.4 Million a decrease over its 2024 earnings that were of -A$29.98 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$33.99 Million11.79%
2025 -A$30.4 Million1.4%
2024 -A$29.98 Million-13.16%
2023 -A$34.53 Million9.83%
2022 -A$31.44 Million-54.24%
2021 -A$68.69 Million86.07%
2020 -A$36.92 Million-31.97%
2019 -A$54.27 Million-5.42%
2018 -A$57.38 Million1.1%
2017 -A$56.75 Million-31.06%
2016 -A$82.31 Million-10.38%
2015 -A$91.85 Million29.69%
2014 -A$70.83 Million31.68%
2013 -A$53.79 Million
2011 -A$26.11 Million89.78%
2010 -A$13.76 Million206.06%
2009 -A$4.5 Million-0.58%
2008 -A$4.52 Million164.89%
2007 -A$1.71 Million-30.22%
2006 -A$2.45 Million
2002 -A$2.84 Million-41.04%
2001 -A$4.82 Million-32.04%
2000 -A$7.09 Million-11.85%
1999 -A$8.04 Million
1997 -A$5.17 Million12.12%
1996 -A$4.61 Million106.25%
1995 -A$2.24 Million-11.11%
1994 -A$2.52 Million50%
1993 -A$1.68 Million20%
1992 -A$1.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.21 Billion 555.55%๐Ÿ‡บ๐Ÿ‡ธ USA